Metabotropic Glutamate Receptor 5 Negative Modulation in Phase I Clinical Trial: Potential Impact of Circadian Rhythm on the Neuropsychiatric Adverse Reactions—Do Hallucinations Matter?
Table 1
Descriptive statistics, Day 1 and Day 7 concentrations (ng/mL), 2 h/4 h after dose.
